Literature DB >> 19904210

Long-term speech and language developmental issues among children with Duarte galactosemia.

Kimberly K Powell1, Kim Van Naarden Braun, Rani H Singh, Stuart K Shapira, Richard S Olney, Marshalyn Yeargin-Allsopp.   

Abstract

PURPOSE: : There is limited information on long-term outcomes among children with Duarte galactosemia and controversy about treatment of this potentially benign condition. This study examined developmental disabilities and issues that required special education services within a population-based sample of children with Duarte galactosemia.
METHODS: : Children born between 1988 and 2001 who were diagnosed with Duarte galactosemia and resided in the five-county metropolitan Atlanta area at birth and from 3 to 10 years of age were linked to the (1) Metropolitan Atlanta Developmental Disabilities Surveillance Program, an ongoing, population-based surveillance system for selected developmental disabilities and (2) Special Education Database of Metropolitan Atlanta. Special education records were reviewed for children who linked. Clinical genetics records were reviewed to assess laboratory levels at the time of diagnosis and metabolic control during treatment.
RESULTS: : Of the 59 eligible children, none were found to have intellectual disability, cerebral palsy, hearing loss, vision impairment, or an autism spectrum disorder. However, five, 8.5% of 3 to 10 years or 15.2% of eligible 8 years, were identified as having received special education services, four of whom were confirmed with a speech or language disorder, or were receiving services for speech or language or both compared with 4.5% and 5.9% of children without Duarte galactosemia, respectively.
CONCLUSIONS: : Despite galactose restriction until 1 year, select developmental issues associated with special education, specifically involving speech and language, have been found among some children with Duarte galactosemia.

Entities:  

Mesh:

Year:  2009        PMID: 19904210     DOI: 10.1097/GIM.0b013e3181c0c38d

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  10 in total

1.  Galactosemia screening with low false-positive recall rate: the Swedish experience.

Authors:  Annika Ohlsson; Claes Guthenberg; Ulrika von Döbeln
Journal:  JIMD Rep       Date:  2011-09-06

2.  A brief overview of galactosemia newborn screening in the United States.

Authors:  Brook M Pyhtila; Kelly A Shaw; Samantha E Neumann; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2014-07       Impact factor: 4.982

Review 3.  Appropriateness of newborn screening for classic galactosaemia: a systematic review.

Authors:  L Varela-Lema; L Paz-Valinas; G Atienza-Merino; R Zubizarreta-Alberdi; R Vizoso Villares; M López-García
Journal:  J Inherit Metab Dis       Date:  2016-04-26       Impact factor: 4.982

4.  Newborn screening for galactosemia: a 30-year single center experience.

Authors:  Francesco Porta; Severo Pagliardini; Veronica Pagliardini; Alberto Ponzone; Marco Spada
Journal:  World J Pediatr       Date:  2015-03-09       Impact factor: 2.764

5.  Developmental Outcomes of School-Age Children with Duarte Galactosemia: A Pilot Study.

Authors:  Mary Ellen Lynch; Nancy L Potter; Claire D Coles; Judith L Fridovich-Keil
Journal:  JIMD Rep       Date:  2015-02-15

6.  Ovarian function in Duarte galactosemia.

Authors:  Jennifer R Badik; Uriel Castañeda; Tyler J Gleason; Jessica B Spencer; Michael P Epstein; Can Ficicioglu; Kristi Fitzgerald; Judith L Fridovich-Keil
Journal:  Fertil Steril       Date:  2011-06-29       Impact factor: 7.329

7.  Newborn screening for galactosemia in the United States: looking back, looking around, and looking ahead.

Authors:  Brook M Pyhtila; Kelly A Shaw; Samantha E Neumann; Judith L Fridovich-Keil
Journal:  JIMD Rep       Date:  2014-04-10

8.  Prevalence and phenotype of childhood apraxia of speech in youth with galactosemia.

Authors:  Lawrence D Shriberg; Nancy L Potter; Edythe A Strand
Journal:  J Speech Lang Hear Res       Date:  2010-10-21       Impact factor: 2.297

9.  Laboratory diagnosis of galactosemia: a technical standard and guideline of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Marzia Pasquali; Chunli Yu; Bradford Coffee
Journal:  Genet Med       Date:  2017-10-26       Impact factor: 8.822

10.  Molecular analysis of GALT gene in Argentinian population: Correlation with enzyme activity and characterization of a novel Duarte-like allele.

Authors:  Carolina Crespo; Hernán Eiroa; María Inés Otegui; Mara Cecilia Bonetto; Lilien Chertkoff; Luis Pablo Gravina
Journal:  Mol Genet Metab Rep       Date:  2020-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.